These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27800226)

  • 1. Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases.
    Karadeniz Uğurlu Ş; Selim S; Kopar A; Songu M
    Turk J Ophthalmol; 2015 Aug; 45(4):169-174. PubMed ID: 27800226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration.
    Zhang J; Kim JD; Beaver HA; Takashima M; Lee AG
    Neuroophthalmology; 2013; 37(5):198-203. PubMed ID: 28167988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraorbital Irrigation of Amphotericin B in the Treatment of Rhino-Orbital Mucormycosis.
    Joos ZP; Patel BC
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e13-e16. PubMed ID: 25794024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbito-cerebral mucormycosis: five cases.
    Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
    Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of limited rhino-orbital mucormycosis without exenteration.
    Kohn R; Hepler R
    Ophthalmology; 1985 Oct; 92(10):1440-4. PubMed ID: 4069609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin.
    Ogawa T; Takezawa K; Tojima I; Shibayama M; Kouzaki H; Ishida M; Okabe H; Shimizu T
    Auris Nasus Larynx; 2012 Apr; 39(2):224-8. PubMed ID: 21592699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.
    Gupta S; Goyal R; Kaore NM
    Indian J Otolaryngol Head Neck Surg; 2020 Mar; 72(1):104-111. PubMed ID: 32158665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center.
    Farooq AV; Patel RM; Lin AY; Setabutr P; Sartori J; Aakalu VK
    Orbit; 2015 Jun; 34(3):152-9. PubMed ID: 25906127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of
    Miller RP; Farrugia L; Leask J; Khalsa K; Khanna N; Melia L
    Med Mycol Case Rep; 2021 Jun; 32():39-42. PubMed ID: 33816097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective.
    Saluja G; Bhari A; Pushker N; Agrawal S; Meel R; Thakar A; Xess I; Khandelwal A; Narwal A; Bajaj MS
    Med J Armed Forces India; 2022 Apr; 79(Suppl 1):S94-S101. PubMed ID: 35400798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B.
    Safi M; Ang MJ; Patel P; Silkiss RZ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100771. PubMed ID: 32551404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of orbital apex syndrome in COVID associated mucormycosis patients in a tertiary care hospital.
    Srivastava SR; Ganguly P; Barman D; Das S; Bandyopadhyay M; Ghosh AK; Sarkar S; Sengupta A; Swaika S; Chatterjee P; Gupta AK; Mondal AR; Guha S; Dutta S; Adhikari S; Kaushik A; Biswas PS; Ayub A
    Int J Ophthalmol; 2022; 15(4):527-532. PubMed ID: 35450177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis.
    Singh P; Gupta A; Sanepalli SR; Raj A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35361668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series.
    Pathak M; Sahu V; Arora RD; Shambharkar MM; Naveen P; Pati SK; Nagarkar NM
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3352-3358. PubMed ID: 36246726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.